1. HEIH Promotes Malignant Progression of Gastric Cancer by Regulating STAT3-Mediated Autophagy and Glycolysis
- Author
-
Huiqing Zhang, Xiaohua Shen, Shuping Xiong, Lixiang Peng, Wenli Mai, and Longxiang Xin
- Subjects
STAT3 Transcription Factor ,Article Subject ,Biochemistry (medical) ,Clinical Biochemistry ,General Medicine ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,Cell Movement ,Stomach Neoplasms ,Cell Line, Tumor ,Autophagy ,Genetics ,Humans ,RNA, Long Noncoding ,Glycolysis ,Molecular Biology ,Cell Proliferation - Abstract
To study the clinical value of HEIH hyperexpression in gastric cancer and the molecular mechanism of promoting malignant proliferation of gastric cancer cells, qRT-PCR was used to detect the expression of HEIH in gastric cancer and nontumor gastric tissues. HEIH interference sequence was constructed to downregulate HEIH expression in MGC-803 and BGC-823 cell lines. CCK8, clonogenesis, and Transwell assay were used to detect the effects of HEIH on proliferation and invasion of tumor cells. The protein levels of STAT3, p-STAT3, P62, and LC3 were detected by Western blotting. The results showed that HEIH was highly expressed in gastric cancer ( P < 0.01 ). Interference of HEIH expression in MGC-803 and BGC-823 cells reduced the proliferation and invasion of gastric cancer cells, and the results were statistically significant ( P < 0.05 ). HEIH acts as a miRNA sponge for miR-4500. HEIH promotes gastric cancer development by inhibiting miR-4500. STAT3 is a downstream target of miR-4500. HEIH inhibits autophagy and promotes glycolysis. In conclusion, HEIH is highly expressed in gastric cancers. HEIH promotes malignant proliferation and development of gastric cancer cells. HEIH may be a new candidate site for pathological diagnosis and molecular drug therapy for future clinical treatment of gastric cancer.
- Published
- 2022